Ken Griffin's Citadel Reveals Top 5 Stock Holdings
ByAinvest
Tuesday, Aug 12, 2025 9:51 am ET1min read
EW--
Charles Schwab (NYSE: SCHW) is Citadel's top stock holding, accounting for roughly 1.6% of its total stock portfolio as of the company's last update. Schwab is a leading financial services provider, offering a wide range of products and services, including brokerage, banking, and investment management.
Invesco QQQ Trust (NASDAQ: QQQ) is an exchange-traded fund (ETF) that tracks the Nasdaq-100 index, making up 1.1% of Citadel's holdings. This ETF provides exposure to a broad range of technology and growth-oriented companies.
Edwards Lifesciences (NYSE: EW) is a medical device company specializing in heart valves and other cardiovascular products. It is a significant holding, reflecting Citadel's interest in the healthcare sector.
Medtronic (NYSE: MDT) is a global leader in medical technology, devices, and services. It is also a notable holding, indicating Citadel's focus on the healthcare industry.
Keurig Dr Pepper (NASDAQ: KDP) is a beverage company known for its single-serve coffee and tea products. This holding represents Citadel's interest in the consumer goods sector.
These holdings demonstrate Citadel's diversified approach, with a significant focus on technology and healthcare sectors. The fund's technology- and analytics-driven strategy has been a key factor in its exceptional performance.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-forsta-ap-fonden-sells-17500-shares-of-keurig-dr-pepper-inc-nasdaqkdp-2025-08-10/
[2] https://finance.yahoo.com/news/billionaire-ken-griffins-5-biggest-195600392.html
IVZ--
KDP--
MDT--
SCHW--
Ken Griffin's Citadel Advisors, the most profitable hedge fund of all time, has disclosed its five largest stock holdings. The top five include Charles Schwab, Invesco QQQ Trust, Edwards Lifesciences, Medtronic, and Keurig Dr Pepper. Citadel's technology- and analytics-focused approach to portfolio construction has contributed to its market-crushing performance.
Citadel Advisors, the most profitable hedge fund of all time, has disclosed its five largest stock holdings, providing insights into its investment strategy. The top five holdings include Charles Schwab, Invesco QQQ Trust, Edwards Lifesciences, Medtronic, and Keurig Dr Pepper. Citadel's technology- and analytics-focused approach to portfolio construction has contributed to its market-crushing performance.Charles Schwab (NYSE: SCHW) is Citadel's top stock holding, accounting for roughly 1.6% of its total stock portfolio as of the company's last update. Schwab is a leading financial services provider, offering a wide range of products and services, including brokerage, banking, and investment management.
Invesco QQQ Trust (NASDAQ: QQQ) is an exchange-traded fund (ETF) that tracks the Nasdaq-100 index, making up 1.1% of Citadel's holdings. This ETF provides exposure to a broad range of technology and growth-oriented companies.
Edwards Lifesciences (NYSE: EW) is a medical device company specializing in heart valves and other cardiovascular products. It is a significant holding, reflecting Citadel's interest in the healthcare sector.
Medtronic (NYSE: MDT) is a global leader in medical technology, devices, and services. It is also a notable holding, indicating Citadel's focus on the healthcare industry.
Keurig Dr Pepper (NASDAQ: KDP) is a beverage company known for its single-serve coffee and tea products. This holding represents Citadel's interest in the consumer goods sector.
These holdings demonstrate Citadel's diversified approach, with a significant focus on technology and healthcare sectors. The fund's technology- and analytics-driven strategy has been a key factor in its exceptional performance.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-forsta-ap-fonden-sells-17500-shares-of-keurig-dr-pepper-inc-nasdaqkdp-2025-08-10/
[2] https://finance.yahoo.com/news/billionaire-ken-griffins-5-biggest-195600392.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet